David Lucas, MD
Neuromusculoskeletal Medicine, Sports Medicine · Clermont, FLNPI 1336131069
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,750 of the $3,683 with a category attached, or 74.7%. Ortho Development Corporation accounts for 82.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2020 at $2,822 and has fallen 91.4% since, to $244 in 2025.
Across 29 payments — averaging $127.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ortho Development Corporation$3K
- Smith+Nephew$175
- Johnson & Johnson$100
- Biocomposites Inc$71
- Medacta USA, Inc.$64
- Reel Surgical, Inc.$47
- plus $175 from 7 others
What the payments were for
- Consulting fees$2,75075%
- Travel & lodging$191%
- Food & beverage$91425%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ortho Development Corporation | 5 | $3,052 |
| Smith+Nephew | 7 | $175 |
| Johnson & Johnson(2 entities) | 5 | $100 |
| Biocomposites Inc | 1 | $71 |
| Medacta USA, Inc. | 1 | $64 |
| Reel Surgical, Inc. | 1 | $47 |
| Stryker | 2 | $43 |
| Orthogrid Systems Inc | 1 | $37 |
| Endo Pharmaceuticals Inc. | 2 | $29 |
| Innovation Technologies Inc | 1 | $23 |
| Intuitive Surgical | 1 | $19 |
| Mimedx Group, Inc. | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few neuromusculoskeletal medicine, sports medicine providers in Floridato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 79 | $425 |
| ErythromycinErythromycin Base | 20 | $390 |
| Amoxicillin | 138 | $192 |
| Methylprednisolone | 18 | $134 |
| Prednisone | 39 | $105 |
| Celecoxib | 13 | $103 |
| Meloxicam | 19 | $93 |
| Oxycodone Hcl | 20 | $60 |
| Tramadol Hcl | 20 | $43 |
Paid to pharmacies, not to this prescriber.
Other neuromusculoskeletal medicine, sports medicine in Clermont
- Kevin NowickiClermont$7K
- Qahtan AbdulfattahBrooksville$17K
- Raymond WeiandPalm Coast$4K
- Larry FishmanBrandon$521
- Raul CorreaBradenton$517
- Stephen WoodLargo$165
- Scott KazdanPembroke Pines$111
- Michael ZiebelmanWinter Haven$18
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.